Search - tctmd.com

Displaying 161 - 180 of 388

Sort: Relevancy | Date

News Daily News

CVD Risk ‘Underappreciated’ After Adverse Pregnancy Outcomes

L.A. McKeown

November 01, 2021

News Opinion CV Team Dispatch

November 2021 News Roundup

L.A. McKeown

November 01, 2021

News Daily News

CAC Tests Boost CAD Prediction in Younger Patients at Risk for ASCVD

Yael L. Maxwell

October 14, 2021

News Conference News VIVA 2021

Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI

L.A. McKeown

October 08, 2021

News Daily News

Diabetes Progression in Statin-Treated Patients: VA Data

Michael O'Riordan

October 06, 2021

News Daily News

Early Menopause Linked to Increased ASCVD Risk

L.A. McKeown

September 17, 2021

News Daily News

As CDC Moves to Update Contraception Guidance, Cardiologists Should Take Note

Alexandra Dangas

September 06, 2021

News Conference News ESC 2021

Finerenone Reduces CV Outcomes in Patients With Early CKD, Diabetes: FIGARO-DKD

Michael O'Riordan

August 28, 2021

News Daily News

Food Insecurity Common Among Patients With ASCVD

Michael O'Riordan

August 18, 2021

News Daily News

ASCVD Risk in South Asians Far Exceeds Forecasts by Common Scores

Shelley Wood

July 12, 2021

News Daily News

FDA Approves Finerenone for Adults With CKD and Type 2 Diabetes

Yael L. Maxwell

July 09, 2021

News Daily News

Empagliflozin Succeeds in HFpEF: EMPEROR-Preserved Top-line Results

Todd Neale

July 06, 2021

News Daily News

Sleep Apnea Awareness, Treatment May Improve Some CVD Outcomes: AHA

L.A. McKeown

June 23, 2021

News Daily News

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

Michael O'Riordan

June 16, 2021

News Daily News

First PCIs Preceded by Many Modifiable Risk Factors: Registry Data

L.A. McKeown

June 16, 2021

News Opinion CV Team Dispatch

June 2021 News Roundup

L.A. McKeown

June 01, 2021

News Daily News

Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care

Shelley Wood

May 27, 2021

News Daily News

Finerenone Cuts CV Events in CKD Patients With Diabetes: FIGARO-DKD

Michael O'Riordan

May 11, 2021

News Conference News ACC 2021

Prediabetes Linked to Higher MACE Risk

Todd Neale

May 10, 2021

News Conference News ACC 2021

Social Determinants of Health Tied to Fewer COVID-19 Precautions in CVD Patients

Caitlin E. Cox

May 07, 2021

Advertisement

CVD Risk ‘Underappreciated’ After Adverse Pregnancy Outcomes

November 2021 News Roundup

CAC Tests Boost CAD Prediction in Younger Patients at Risk for ASCVD

Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI

Diabetes Progression in Statin-Treated Patients: VA Data

Early Menopause Linked to Increased ASCVD Risk

As CDC Moves to Update Contraception Guidance, Cardiologists Should Take Note

Finerenone Reduces CV Outcomes in Patients With Early CKD, Diabetes: FIGARO-DKD

Food Insecurity Common Among Patients With ASCVD

ASCVD Risk in South Asians Far Exceeds Forecasts by Common Scores

FDA Approves Finerenone for Adults With CKD and Type 2 Diabetes

Empagliflozin Succeeds in HFpEF: EMPEROR-Preserved Top-line Results

Sleep Apnea Awareness, Treatment May Improve Some CVD Outcomes: AHA

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

First PCIs Preceded by Many Modifiable Risk Factors: Registry Data

June 2021 News Roundup

Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care

Finerenone Cuts CV Events in CKD Patients With Diabetes: FIGARO-DKD

Prediabetes Linked to Higher MACE Risk

Social Determinants of Health Tied to Fewer COVID-19 Precautions in CVD Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content